A comparison of sequencing platforms and bioinformatics pipelines for compositional analysis of the gut microbiome

Abstract

BackgroundAdvancements in Next Generation Sequencing (NGS) technologies regarding throughput, read length and accuracy had a major impact on microbiome research by significantly improving 16S rRNA amplicon sequencing. As rapid improvements in sequencing platforms and new data analysis pipelines are introduced, it is essential to evaluate their capabilities in specific applications. The aim of this study was to assess whether the same project-specific biological conclusions regarding microbiome composition could be reached using different sequencing platforms and bioinformatics pipelines.ResultsChicken cecum microbiome was analyzed by 16S rRNA amplicon sequencing using Illumina MiSeq, Ion Torrent PGM, and Roche 454 GS FLX Titanium platforms, with standard and modified protocols for library preparation. We labeled the bioinformatics pipelines included in our analysis QIIME1 and QIIME2 (de novo OTU picking [not to be confused with QIIME version 2 commonly referred to as QIIME2]), QIIME3 and QIIME4 (open reference OTU picking), UPARSE1 and UPARSE2 (each pair differs only in the use of chimera depletion methods), and DADA2 (for Illumina data only). GS FLX+ yielded the longest reads and highest quality scores, while MiSeq generated the largest number of reads after quality filtering. Declines in quality scores were observed starting at bases 150–199 for GS FLX+ and bases 90–99 for MiSeq. Scores were stable for PGM-generated data. Overall microbiome compositional profiles were comparable between platforms; however, average relative abundance of specific taxa varied depending on sequencing platform, library preparation method, and bioinformatics analysis. Specifically, QIIME with de novo OTU picking yielded the highest number of unique species and alpha diversity was reduced with UPARSE and DADA2 compared to QIIME.ConclusionsThe three platforms compared in this study were capable of discriminating samples by treatment, despite differences in diversity and abundance, leading to similar biological conclusions. Our results demonstrate that while there were differences in depth of coverage and phylogenetic diversity, all workflows revealed comparable treatment effects on microbial diversity. To increase reproducibility and reliability and to retain consistency between similar studies, it is important to consider the impact on data quality and relative abundance of taxa when selecting NGS platforms and analysis tools for microbiome studies.Electronic supplementary materialThe online version of this article (10.1186/s12866-017-1101-8) contains supplementary material, which is available to authorized users.

Systematic review: the effects of proton pump inhibitors on the microbiome of the digestive tract—evidence from next‐generation sequencing studies

“…Targeted sequencing of amplicons of the variable regions of the 16S rRNA is the most widely used approach for the identification of bacterial taxa and their relative abundance. However, a sufficient sequence coverage is required for obtaining resolutions down to species level, and there are concerns regarding reproducibility between the established sequencing platforms and computational tools …”

“…coverage is required for obtaining resolutions down to species level, and there are concerns regarding reproducibility between the established sequencing platforms and computational tools. [38][39][40] The application of next-generation sequencing indicated numerous associations between gastrointestinal conditions and altered composition of the microbiome, for example in inflammatory bowel disease 41 and C difficile infection, 42 and a wide range of non-intestinal diseases such as type 1 and 2 diabetes, 43,44 liver and cardiovascular disease, 45,46 rheumatic diseases, 47 multiple sclerosis 48 and autism-spectrum disorders. 49 Microbiome compositions that differ from a balanced, healthy state are often referred to as dysbiosis, although there is no consensus on the composition of a eubiotic, healthy microbiome, nor is there a widely agreed definition of the term dysbiosis.…”

Disturbance in human gut microbiota networks by parasites and its implications in the incidence of depression

“…Briefly, once feces were collected into 1.5mL sterile tubes, we diluted each sample with 180 µl of ATL extraction buffer with 20 µl proteinase K (10 mg ml 1 − Analysis of the sequence data. The paired-end 2 × 250 reads were processed in QIIME2 65 . The reads were denoised with the DADA2 plugin to resolve the amplicon sequence variants (ASVs).…”

The Labyrinth of Product Development and Regulatory Approvals in Liquid Biopsy Diagnostics

“…There are challenges in the accurate detection of all possible variant types in tissue biopsies . These are exacerbated by the uncertainty and bias in different pipeline software products for calling these variants. Performance requirements for liquid biopsies represent a major analytical challenge for NGS chemistries and hardware.…”